AbbVie Joins US Drug Rebate Pilot
AbbVie will participate in a US government pilot starting next year to test a new rebate system for discounted medicines under the 340B program. The initiative aims to improve pricing transparency and prevent duplicate discounts for key drugs.
Xurve View
Insights:
Xurve View

